myirislogo
04 August, 2015 15:11 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 287.35 2.24
Tata Stl 253.25 2.12
Icici Bank 313.75 0.30
Tata Motors 380.75 1.91
Ong Corp 266.55 2.52
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Strides Arcolab Limited
Strides Arcolab Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532531NSE:STARBloomberg:STR@INReuters:STAR.BO
Market Lot: 1Face Value: 10ISIN Demat: INE939A01011
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
31-JUL-15 Strides Arcolab, a pharmaceutical company manufacturing IP-led niche products, today announced that it has received approval from the United States Food & Drug Administration (USFDA) for Benzonatate Softgel Capsules USP, 100 mg and 200 mg. 17-JUN-15 The Central Government on Wednesday approved 16 proposals of foreign direct investment (FDI) amounting to Rs 67.50 billion approximately. Earlier on May 28, Foreign Investment Promotion B...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Strides Arcolab quarterly net zooms 2.20 times   -IRIS 30-Jul-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2015(3)31-Mar-2015 (12)31-Mar-2014 (15)
Net sales 2020.878619.199939.54
Other Income684.601001.751209.34
Total Income2705.479620.9411148.88
Cost of goods sold1943.417954.959153.98
OPBDIT762.061665.991994.90
PAT480.265323.2235129.20
Gross Block---
Equity capital596.26596.16595.66
EPS (Rs.)-89.36593.65
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-4.30 - 13.420.72 - 2.40
Debt / Equity (x)---
Operating margin (% of OI)28.217.317.9
Net margin (% of OI)17.855.3315.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
No 201, Devavrata
Sector 17
Vashi
Navi Mumbai
Maharashtra-400 705
PHONE
(022) 2789 3199/ 5247
FAX
(022) 2789 2924/ 42
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer